Align Technology Shares - weekly review with price data and product context

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/20/2026, 17:36 UTC. Details in the imprint.

Align Technology (US0162551016) starts the weekend with a market snapshot and a weekly review of the stock. No live-verifiable day-of hook was available, so the article uses the Friday-style sector lens and price context instead.

What the week shows

MarketBeat shows Align Technology shares at $182.08, based on a closing price from 06/18/2026 at 04:00 PM Eastern. The same page lists extended trading at $179.30 as of 06/18/2026 at 06:26 PM Eastern.

The stock has also moved higher year to date from $156.15 at the start of 2026, according to the same market page. That puts the weekly lens on valuation, sentiment, and comparison with other healthcare equipment names.

Peers and positioning

TradingKey classifies Align Technology in Healthcare Equipment & Supplies and assigns the stock a beta of 1.68. That points to larger swings than the market during stronger or weaker tape.

For a peer-group read, that matters more than a single day move. It helps explain why the shares can react sharply to earnings, guidance, or margin commentary.

What the company sells

Align Technology builds the Invisalign clear aligner system and the iTero intraoral scanner platform. Those products sit at the center of its orthodontic and digital dentistry business.

The company sells to dental professionals, not directly to consumers. That makes procedure volumes, adoption, and workflow efficiency more important than retail demand.

Where the stock trades today

The shares of Align Technology trade on Nasdaq at $182.08 as of 06/18/2026, 04:00 PM ET, according to MarketBeat.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.